DOI: 10.1055/s-00034922

Arthritis und Rheuma

References

van Vollenhoven RF, Zamani O, Wallace DJ. et al.
Belimumab, a BLyS-specific inhibitor, reduces disease activity and severe flares in seropositive SLE patients: BLISS-76 study.

Ann Rheum Dis 2010;
69: 74.

Download Bibliographical Data